ARIAD Pharmaceuticals Inc (ARIA): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

ARIAD Pharmaceuticals ( ARIA) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 1.2%. By the end of trading, ARIAD Pharmaceuticals fell $0.33 (-4.7%) to $6.69 on average volume. Throughout the day, 17,621,627 shares of ARIAD Pharmaceuticals exchanged hands as compared to its average daily volume of 19,029,800 shares. The stock ranged in price between $6.23-$7.05 after having opened the day at $7.02 as compared to the previous trading day's close of $7.02. Other companies within the Health Care sector that declined today were: Transition Therapeutics ( TTHI), down 30.6%, Auspex Pharmaceuticals ( ASPX), down 19.1%, uniQure ( QURE), down 18.5% and Tekmira Pharmaceuticals Corporation ( TKMR), down 14.3%.

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. ARIAD Pharmaceuticals has a market cap of $1.3 billion and is part of the drugs industry. Shares are up 2.9% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate ARIAD Pharmaceuticals a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates ARIAD Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.

On the positive front, 22nd Century Group ( XXII), up 26.4%, BG Medicine ( BGMD), up 13.4%, Cardica ( CRDC), up 10.6% and KYTHERA Biopharmaceuticals ( KYTH), up 9.9% , were all gainers within the health care sector with Johnson & Johnson ( JNJ) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices